Is the LINX reflux management system an effective treatment for gastro-oesophageal reflux disease?

A best evidence topic in surgery was written according to a structured protocol. The question addressed whether LINX (TM) Reflux management system is an efficacious treatment for patients with symptoms of gastro-oesophageal reflux disease (GORD) not controlled by proton pump inhibitors (PPI). Forty-eight LINX-related papers were identified using the reported search, of which three represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group, study type, relevant outcomes and results of these papers are tabulated. All three studies were prospective case studies. They demonstrated that LINX is an efficacious treatment for GORD patients with good short and medium term outcomes and an acceptable safety profile. Further studies are required to determine its long term outcomes and its relative efficacy as compared to other established treatments. (C) 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.